NEW YORK, Nov. 14, 2016
/PRNewswire/ -- Tonight, on World Diabetes Day, the spire of One
World Trade Center will be lit in blue, the official color of
diabetes, to raise awareness of the disease.
The lighting results from the collective efforts of The American
Diabetes Association®, JDRF, The New York Stem Cell
Foundation Research Institute and Novo Nordisk Inc. in
collaboration with the Consulate General of Denmark in New
York. The organizations are united in the battle against
diabetes though prevention, detection, treatment and research.
Nearly 30 million Americans have diabetes and at least another
86 million have prediabetes. Without intervention, as many as 30
percent of those with prediabetes will likely develop type 2
diabetes within five years1. Every 23 seconds,
someone in the U.S. is diagnosed with diabetes2.
Blue became the official color of diabetes in 2006 when the
International Diabetes Federation developed the blue circle icon to
serve as the global symbol for diabetes. The organization selected
blue to reflect the color of the sky and of the United Nations'
flag.3
About the American Diabetes Association
The American
Diabetes Association is leading the fight to Stop Diabetes® and its
deadly consequences and fighting for those affected by diabetes.
The Association funds research to prevent, cure and manage
diabetes; delivers services to hundreds of communities; provides
objective and credible information; and gives voice to those denied
their rights because of diabetes. For the past 75 years, our
mission has been to prevent and cure diabetes and to improve the
lives of all people affected by diabetes. For more information
please call the American Diabetes Association at 1-800-DIABETES
(800-342-2383) or visit diabetes.org. Information from both
these sources is available
in English and Spanish.
About JDRF
JDRF is the leading global organization
funding type 1 diabetes (T1D) research. Our mission is to
accelerate life-changing breakthroughs to cure, prevent and treat
T1D and its complications. To accomplish this, JDRF has invested
nearly $2 billion in research funding
since our inception. We are an organization built on a grassroots
model of people connecting in their local communities,
collaborating regionally for efficiency and broader fundraising
impact, and uniting on a national stage to pool resources, passion,
and energy. We collaborate with academic institutions,
policymakers, and corporate and industry partners to develop and
deliver a pipeline of innovative therapies to people living with
T1D. Our staff and volunteers throughout the United States and our six international
affiliates are dedicated to advocacy, community engagement and our
vision of a world without T1D. For more information, please visit
jdrf.org or follow us on Twitter: @JDRF.
About The New York Stem Cell Foundation Research
Institute
The New York Stem Cell Foundation (NYSCF) Research
Institute is an independent organization accelerating cures and
better treatments for patients through stem cell research. The
NYSCF global community includes over 140 researchers at leading
institutions worldwide, including the NYSCF – Druckenmiller
Fellows, the NYSCF – Robertson Investigators, the NYSCF – Robertson
Stem Cell Prize Recipients, and NYSCF Research Institute scientists
and engineers. The NYSCF Research Institute employs over 45
researchers in New York, and is an
acknowledged world leader in stem cell research and in developing
pioneering stem cell technologies, including the NYSCF Global Stem
Cell ArrayTM. NYSCF focuses on translational research in
a model designed to overcome the barriers that slow discovery and
replace silos with collaboration. For more information, visit
www.nyscf.org
About the Consulate General of Denmark
The Consulate General of
Denmark in New York is Denmark's official representation in
New York. We advise and assist in
a number of areas: consular, commercial, investment, cultural and
press.
We communicate to the U.S. public on important policy topics
with relevance to Denmark, such as
green growth, sustainable development and life sciences.
About Novo Nordisk
Novo Nordisk is a global
health care company with more than 90 years of innovation and
leadership in diabetes care. This heritage has given us experience
and capabilities that also enable us to help people defeat other
serious chronic conditions: hemophilia, growth disorders and
obesity. With U.S. headquarters in Plainsboro, N.J., Novo Nordisk Inc. has nearly
5,000 employees in the United
States. For more information, visit novonordisk.us or follow
us on Twitter: @novonordiskus.
1 http://www.cdc.gov/diabetes/data/
2
http://www.cdc.gov/diabetes/statistics/incidence/fig1.htm
3 https://www.idf.org/bluecircle
Logo -
http://photos.prnewswire.com/prnh/20110414/NY80976LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/one-world-trade-center-to-glow-blue-in-honor-of-world-diabetes-day-tonight-300361567.html
SOURCE Novo Nordisk